U.S. Infrastructure Stock News

NYSE:MCD
NYSE:MCDHospitality

McDonald's Workplace Violence Case Puts Focus On Safety And MCD Valuation

A McDonald's employee in Yuba City, California, reportedly suffered severe burns after a coworker allegedly threw hot oil on him. The incident occurred at a franchise location and has resulted in criminal charges against the alleged attacker. The case is drawing renewed attention to workplace safety and culture across McDonald's global operations. For investors watching NYSE:MCD, this incident adds a qualitative factor to consider alongside the current share price of $284.77. The stock is...
NYSE:SMR
NYSE:SMRElectrical

Is NuScale Power’s (SMR) Expanding E2 Center Network Quietly Rewriting Its Nuclear Investment Narrative?

NuScale Power recently opened its 12th Energy Exploration (E2) Center at the University of Virginia’s College at Wise, funded by the Virginia Clean Energy Innovation Bank to support nuclear education and workforce transition in southwest Virginia. This expansion of NuScale’s global E2 Center network highlights how the company is investing in training infrastructure that could underpin future adoption of its small modular reactor technology. We’ll now examine how NuScale’s growing E2 Center...
NYSE:FIG
NYSE:FIGSoftware

Figma (FIG) Stock Valuation Looks Slightly Stretched After Recent Weak Performance

Figma stock reaction and recent context Figma (FIG) has drawn investor attention after recent trading left the stock around $19.34, with short term performance mixed, including a decline over the past 3 months and year to date. See our latest analysis for Figma. With the share price at $19.34, Figma’s recent stretch has been weak, with the 7 day share price return down 14.08% and the 90 day share price return down 25.70%, pointing to fading momentum despite a flat 30 day move. If this kind of...
NasdaqGS:NWPX
NasdaqGS:NWPXConstruction

Why NWPX Infrastructure (NWPX) Is Up 5.4% After Debuting Curved Microtunneling Steel Pipe Technology

NWPX Infrastructure, Inc. recently completed the first real‑world installation of its patent‑pending Permalok Radial Bending Joint technology during an emergency wastewater microtunneling project beneath New Jersey’s Pleasure Bay, enabling steel casing pipe to follow intentionally curved underground routes. This field proof-of-concept created what the company describes as the world’s first intentionally curved steel microtunnel, opening up new options for trenchless water and wastewater...
NYSE:CVS
NYSE:CVSHealthcare

Is CVS (CVS) Using GLP-1 Coverage And AI To Redefine Its Integrated Care Advantage?

Recently, CVS Health expanded access to GLP-1 weight management drugs by reintroducing Zepbound and easing access to Foundayo, while also ramping up AI use across pharmacy operations and mental health services. These moves highlight CVS Health's push to use advanced technology and broader drug coverage to make care more accessible and cost-effective across its integrated platform. Next, we’ll examine how the expanded GLP-1 coverage could influence CVS Health’s investment narrative and...
NasdaqGS:FSLR
NasdaqGS:FSLRSemiconductor

Why First Solar (FSLR) Is Down 13.9% After Rising Tax Credits Meet ITC Trade Scrutiny

In recent days, First Solar updated guidance to include an estimated US$2.10–US$2.19 billion in Section 45X manufacturing tax credits while facing policy and trade uncertainties, including a U.S. International Trade Commission investigation into certain solar products. At the same time, significant insider stock sales and wider geopolitical jitters have heightened investor focus on the company’s risk profile despite supportive U.S. incentives. We’ll now examine how heightened policy and...
NasdaqGS:ARM
NasdaqGS:ARMSemiconductor

Arm (NasdaqGS:ARM) Stock Valuation Check As Sector Volatility And Profit Taking Drive Recent Swings

Arm Holdings (NasdaqGS:ARM) has been swinging sharply as semiconductor stocks react to cautious commentary from peers, profit taking, and wider risk off sentiment. Sector mood rather than company headlines is in the driver’s seat. See our latest analysis for Arm Holdings. The stock’s recent 11.32% 1 day share price return follows a period of profit taking and sector wide volatility, but its 64.60% 30 day and 198.29% year to date share price returns point to strong, albeit choppy, momentum,...
NYSE:PRU
NYSE:PRUInsurance

Prudential Faces Japan Setback As Downgrade And Insider Selling Stir Debate

Prudential Financial (NYSE:PRU) has extended its suspension of new sales in Japan, affecting one of its key international markets. Following the extended suspension, Argus downgraded its rating on Prudential Financial, citing the Japan business challenges. Insider selling activity at Prudential Financial has increased around the time of these developments. For investors tracking NYSE:PRU, these company specific events come as the stock trades at $106.51, with the share price up 3.1% over...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

Teva Extends Neuroscience Focus With Emalex Deal And Valuation Upside Potential

Teva Pharmaceutical Industries (NYSE:TEVA) has completed its acquisition of Emalex Biosciences. The deal adds ecopipam, an FDA-designated orphan drug candidate for pediatric Tourette syndrome, to Teva's late-stage neuroscience pipeline. This move aligns with Teva's Pivot to Growth strategy by increasing its focus on specialty neuroscience assets. For investors tracking NYSE:TEVA, the Emalex deal follows a period of strong stock performance, with the share price at $34.56 and the 1-year...
NYSE:WAT
NYSE:WATLife Sciences

Waters Targets Biopharma And Battery Growth With New Analytical Platforms

Waters Corporation (NYSE:WAT) has launched new BioResolve and GTxResolve Columns aimed at speeding impurity analysis in biopharmaceutical workflows. The company introduced two mass spectrometry platforms, the Cyclic IMS P20 and Xevo MRT P10, designed to increase speed, sensitivity, and multiomics capabilities. Waters also released a new Coin Cell DSC instrument focused on safer battery development and testing. Waters, known for its analytical instruments and consumables, is leaning into...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Is New AI Foundry Deal Flow Altering The Investment Case For Intel’s Dual Role (INTC)?

In early June 2026, Cadence Design Systems announced an expanded multi‑year collaboration with Intel Foundry on Design Technology Co‑Optimization for Intel’s 14A process, while Hitachi and Phison separately unveiled new partnerships with Intel spanning foundry tools, quantum computing, physical AI, and enabling larger AI models on Intel-powered PCs. Taken together with a large 2028 Google TPU manufacturing order and new rackscale AI and Xeon 6+ launches, these alliances strengthen Intel’s...
NYSE:VST
NYSE:VSTRenewable Energy

Will Helix AI Data Center Power Deal Redefine Vistra's (VST) Narrative in the AI Era?

KKR, Kuwait Investment Authority, Nvidia, and Vistra recently launched Helix Digital Infrastructure, a more than US$10.00 billion AI data center venture that designates Vistra as its preferred power provider for hyperscale facilities. This role anchors Vistra at the center of coordinating large-scale, long-duration power supply for AI infrastructure, tying its generation fleet directly to the energy-hungry buildout of next-generation data centers. We’ll now examine how Vistra’s role as...
NYSE:RMD
NYSE:RMDMedical Equipment

ResMed (RMD) Stock After 21% Year-To-Date Slide Is There An Opportunity Now

If you are wondering whether ResMed at around US$192 per share offers value or just more volatility, the starting point is understanding what the current price actually reflects. The stock is down 1.0% over the past week, 5.6% over the past month, and 21.4% year to date, with a 23.0% decline over the last year and 16.4% over five years, which may change how investors are thinking about both risk and opportunity. Much of the recent conversation around ResMed has focused on how the company is...
NYSE:WHR
NYSE:WHRConsumer Durables

Whirlpool (WHR) Stock Valuation Revisited After Mixed Short And Long Term Returns

Whirlpool (WHR) has drawn fresh attention after recent share performance data showed mixed returns, including gains over the past week and month alongside declines over the past 3 months and year to date. See our latest analysis for Whirlpool. At a share price of US$42.41, Whirlpool’s recent performance has been mixed, with short term momentum improving, such as a 7 day share price return of 6.02%, against a much weaker multi year total shareholder return, including a 5 year total shareholder...
NYSE:FUL
NYSE:FULChemicals

Does H.B. Fuller’s (FUL) 57-Year Dividend Streak Reveal Its True Capital Return Priorities?

In recent days, commentary around H.B. Fuller has highlighted its 57-year dividend growth record and reputation as a leading global adhesives manufacturer, with some analysts arguing that the shares appear materially undervalued relative to the company’s long-term fundamentals. This focus on dividend durability and perceived undervaluation has reinforced the view that H.B. Fuller’s capital return discipline is a core pillar of its investment appeal. Against that backdrop, we’ll explore how...
NYSE:PSN
NYSE:PSNProfessional Services

Parsons (PSN) Stock After New Air Force GARDEM Contracts And AI Counter Drone Trial

Parsons (PSN) stock is drawing fresh attention after a series of U.S. Air Force Research Laboratory contracts tied to the GARDEM 2 program and a successful AI-enabled counter drone systems demonstration in operational conditions. See our latest analysis for Parsons. Those contract wins and AI-enabled defense milestones come as Parsons’ 1 month share price return of 8.69% contrasts with a year to date share price decline of 7.92%. Over the same period, the 1 year total shareholder return has...
NYSE:WS
NYSE:WSMetals and Mining

Should Worthington Steel’s GM Honors Reshape How Investors View Its Auto Partnerships and Pricing Power (WS)?

Worthington Steel, Inc. was recently named a GM Supplier of the Year winner in General Motors' 34th annual Supplier of the Year awards, marking its fifth recognition since 2020 and third consecutive win. This continued acknowledgement from a major global automaker underscores Worthington Steel’s ongoing role in supporting critical automotive supply chains and innovation initiatives. We’ll now examine how Worthington Steel’s repeated GM Supplier of the Year recognition might influence its...
NasdaqGS:OPEN
NasdaqGS:OPENReal Estate

Opendoor Refocuses On U.S. AI Teams As India Exit Reshapes Risks

Opendoor Technologies is closing its India operations to centralize work in the U.S. The company plans to build AI native teams in the U.S., reshaping how it allocates global resources. This shift reflects how AI is influencing both product workflows and traditional outsourcing models. For investors tracking NasdaqGS:OPEN, this move comes as the stock trades around $4.47 and has had a very large 1 year return, while still being down 73.4% over 5 years and 26.4% year to date. The decision to...
NYSE:ABT
NYSE:ABTMedical Equipment

Abbott Laboratories (ABT) Stock Valuation Check After Recent Mixed Performance

Recent performance snapshot Abbott Laboratories (ABT) has seen mixed share performance recently, with the stock edging up about 0.5% in the latest session and showing a gain over the past month but declines over the past 3 months and year to date. See our latest analysis for Abbott Laboratories. The latest moves come against a weak backdrop, with the share price down about 17% over the past 90 days and the 1 year total shareholder return declining roughly 33%. As a result, recent momentum...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Court Win Lifts Clover Health Star Rating And Future Revenue Potential

Clover Health Investments (NasdaqGS:CLOV) secured a court ruling requiring the Centers for Medicare & Medicaid Services to recalculate its 2026 Medicare Star Rating. The US District Court decision results in an upgrade for Clover Health's main PPO plan from 3.5 to 4.5 stars. The higher rating is expected to increase future CMS bonus payments tied to that plan's performance. The ruling reverses a prior downgrade and strengthens Clover Health's position within the Medicare Advantage...
NasdaqGS:STX
NasdaqGS:STXTech

Seagate Capacity Lock In Resets Growth Outlook And Valuation Debate

Seagate Technology Holdings (NasdaqGS:STX) has secured near-full allocation of its nearline hard drive capacity through calendar 2027. The long term commitments are backed by multi year purchase agreements with key customers. Management has raised its annual revenue growth target to at least 20% based on this contracted demand. For investors watching Seagate at a share price of $868.09, this capacity lock in comes after a period of very strong stock performance, including a return of 201.9%...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

US Stock Market Today: S&P 500 Futures Rise As Energy Inflation Tests Fed Patience

The Morning Bull - US Market Morning Update Friday, Jun, 12 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 contracts up around 0.8%, as investors weigh stubborn energy driven inflation against hopes the Federal Reserve can stay patient on interest rates. May consumer prices in the US rose 0.5% in a single month, with gasoline up 7%, which keeps the pressure on household budgets and mortgage rates, now at 6.6%. At the same time, producer prices for May are expected...
NasdaqGS:LITE
NasdaqGS:LITECommunications

Lumentum Targets Near Packaged Optics As Next AI Data Center Catalyst

Lumentum Holdings (NasdaqGS:LITE) CEO highlighted near-packaged optics, or NPO, as a major new growth driver for the company. Management indicated that NPO could become a larger opportunity than the current focus on co-packaged optics, or CPO. The CEO pointed to a potentially meaningful impact from NPO beginning in fiscal 2027 to 2028. Lumentum operates in optical and photonics technologies that sit inside the broader semiconductor and AI infrastructure supply chain. As data centers scale...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Axsome Therapeutics (AXSM) Stock Valuation Update After Strong Recent Momentum

Axsome Therapeutics (AXSM) has drawn attention after recent trading, with the stock closing at US$253.77. Investors are weighing this move against the company’s central nervous system focused drug portfolio and ongoing clinical programs. See our latest analysis for Axsome Therapeutics. The recent 3.02% 1 day share price return, along with a 62.59% 90 day share price return and 138.84% 1 year total shareholder return, points to strong momentum as investors reassess Axsome Therapeutics’ CNS...